19 December 2020 6 Min Read
US clears Moderna jab for use as second Covid-19 vaccine
Moderna and manufacturing partner Lonza plan to produce 500-million to 1-billion total doses of its vaccine in 2021
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In